11.03.2022

Shaub, Ahmuty, Citrin & Spratt Earns Tier 1 Best Law Firm Rankings

Shaub, Ahmuty, Citrin & Spratt LLP (SACS) is pleased to announce that the firm has been named a 2023 U.S. News – Best LawyersÒ Tier 1 Long Island “Best Law Firm” in the following two practice areas:

  • Medical Malpractice Law – Defendants
  • Personal Injury Litigation – Defendants

“The SACS attorneys strive to aggressively and efficiently achieve favorable results for our clients. We are proud to serve our clients and to receive this prominent ranking,” said SACS Founding Partner Henry Shaub.

The U.S. News – Best LawyersÒ “Best Law Firms” list ranks more than 22,000 firms. Rankings are based on an evaluation process that includes the collection of client and lawyer evaluations, peer review from leading lawyers, and review of additional information provided by law firms as part of the formal submission process. To be eligible for a ranking in a particular practice area and metropolitan region, a law firm must have at least one lawyer who is included in Best Lawyers in that particular practice and metropolitan area.

The SACS Medical Malpractice Defense team has decades of experience navigating liability in the healthcare industry. The team serves healthcare providers from every area of medicine in accusations of negligence. SACS represents healthcare entities and individual practitioners throughout New York, providing resolute representation throughout every stage of a matter, from pre-suit concerns to settlement or trial.

The SACS Personal Injury team works alongside trial defense teams to provide insurer clients with support and guidance. The firm’s attorneys analyze the risk and value of a particular action; evaluate case strategies; draft dispositive motions and motions in limine; advise on case resolution; monitor trials; and handle any subsequent appeals.

The complete methodology for the 2023 edition of the “Best Law Firms” list can be found here.

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use